PT  - JOURNAL ARTICLE
AU  - TANAKA, TOMOKO
AU  - FUJITA, MITSUGU
AU  - HASEGAWA, HIROSHI
AU  - ARIMOTO, AKIRA
AU  - NISHI, MASAYASU
AU  - FUKUOKA, EIJI
AU  - SUGITA, YUTAKA
AU  - MATSUDA, TAKERU
AU  - SUMI, YASUO
AU  - SUZUKI, SATOSHI
AU  - KAKEJI, YOSHIHIRO
AU  - YAMASHITA, KIMIHIRO
TI  - Frequency of Myeloid-derived Suppressor Cells in the Peripheral Blood Reflects the Status of Tumor Recurrence
DP  - 2017 Jul 01
TA  - Anticancer Research
PG  - 3863--3869
VI  - 37
IP  - 7
4099  - http://ar.iiarjournals.org/content/37/7/3863.short
4100  - http://ar.iiarjournals.org/content/37/7/3863.full
SO  - Anticancer Res2017 Jul 01; 37
AB  - Background: Malignant tumors inhibit antitumor immune responses, which are driven by T-regulatory cells or myeloid-derived suppressor cells (MDSCs). Since MDSCs are involved in invasion, migration, and metastasis of tumor cells, we hypothesized that MDSCs are also involved in tumor recurrence after surgical resection. Materials and Methods: C57BL/6 mice were subcutaneously inoculated with B16F10 melanoma cells in the right flank. In some experiments, established tumors were surgically resected. Peripheral blood was drawn over time, and immune cells and cytokines were evaluated using flow cytometry. Results: MDSCs and relevant pro-inflammatory cytokines increased in the peripheral blood of tumor-bearing mice. Moreover, the frequency of MDSCs rapidly increased in mice with tumor recurrence. Conclusion: The frequency of MDSCs in the peripheral blood of tumor-bearing mice reflects the status of tumor progression as well as tumor recurrence. Continuous monitoring of MDSCs in the peripheral blood might be a useful indicator of tumor recurrence.